DIN 00723754 — APRESOLINE 20 MG
APRESOLINE is a solution of Hydralazine marketed by STERIMAX INC. The full Hydralazine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00723754
- Brand name
- APRESOLINE
- Active ingredient
- Hydralazine
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- DORMANT
- Drug class
- Direct-acting arteriolar vasodilator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hydralazine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00441619 | APO-HYDRALAZINE | 10 MG | TABLET | APOTEX INC | MARKETED |
| 00441627 | APO-HYDRALAZINE | 25 MG | TABLET | APOTEX INC | MARKETED |
| 00441635 | APO-HYDRALAZINE | 50 MG | TABLET | APOTEX INC | MARKETED |
| 02539802 | HYDRALAZINE | 10 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02539810 | HYDRALAZINE | 25 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02539829 | HYDRALAZINE | 50 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02516160 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | 20 MG | SOLUTION | AURO PHARMA INC | MARKETED |
| 02537699 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | 20 MG | SOLUTION | EUGIA PHARMA INC. | MARKETED |
| 02457865 | JAMP-HYDRALAZINE | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02457873 | JAMP-HYDRALAZINE | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02457881 | JAMP-HYDRALAZINE | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02468778 | MINT-HYDRALAZINE | 10 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02468786 | MINT-HYDRALAZINE | 25 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02468794 | MINT-HYDRALAZINE | 50 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |